TY - JOUR
T1 - The DSM-5 criteria, level of arousal and delirium diagnosis
T2 - Inclusiveness is safer
AU - European Delirium Association
AU - American Delirium Society
AU - Boustani, Malaz
AU - Rudolph, Jim
AU - Shaughnessy, Marianne
AU - Gruber-Baldini, Ann
AU - Alici, Yesne
AU - Arora, Rakesh C.
AU - Campbell, Noll
AU - Flaherty, Joseph
AU - Gordon, Sharon
AU - Kamholz, Barbara
AU - Maldonado, Jose R.
AU - Pandharipande, Pratik
AU - Parks, Joyce
AU - Waszynski, Christine
AU - Khan, Babar
AU - Neufeld, Karin
AU - Olofsson, Birgitta
AU - Thomas, Christine
AU - Young, John
AU - Davis, Daniel
AU - Laurila, Jouko
AU - Page, Valerie
AU - Teodorczuk, Andrew
AU - Agar, Meera
AU - Meagher, David
AU - Spiller, Juliet
AU - Schieveld, Jan
AU - Milisen, Koen
AU - de Rooij, Sophia
AU - van Munster, Barbara
AU - Kreisel, Stefan
AU - Cerejeira, Joaquim
AU - Hasemann, Wolfgang
AU - Wilson, Dan
AU - Cunningham, Colm
AU - Morandi, Alessandro
AU - Slooter, Arjen
AU - Detroyer, Elke
AU - Caraceni, Augusto
AU - MacLullich, Alasdair
PY - 2014/9/25
Y1 - 2014/9/25
N2 - Background: Delirium is a common and serious problem among acutely unwell persons. Alhough linked to higher rates of mortality, institutionalisation and dementia, it remains underdiagnosed. Careful consideration of its phenomenology is warranted to improve detection and therefore mitigate some of its clinical impact. The publication of the fifth edition of the Diagnostic and Statistical Manual of the American Psychiatric Association (DSM-5) provides an opportunity to examine the constructs underlying delirium as a clinical entity.Discussion: Altered consciousness has been regarded as a core feature of delirium; the fact that consciousness itself should be physiologically disrupted due to acute illness attests to its clinical urgency. DSM-5 now operationalises 'consciousness' as 'changes in attention'. It should be recognised that attention relates to content of consciousness, but arousal corresponds to level of consciousness. Reduced arousal is also associated with adverse outcomes. Attention and arousal are hierarchically related; level of arousal must be sufficient before attention can be reasonably tested.Summary: Our conceptualisation of delirium must extend beyond what can be assessed through cognitive testing (attention) and accept that altered arousal is fundamental. Understanding the DSM-5 criteria explicitly in this way offers the most inclusive and clinically safe interpretation.
AB - Background: Delirium is a common and serious problem among acutely unwell persons. Alhough linked to higher rates of mortality, institutionalisation and dementia, it remains underdiagnosed. Careful consideration of its phenomenology is warranted to improve detection and therefore mitigate some of its clinical impact. The publication of the fifth edition of the Diagnostic and Statistical Manual of the American Psychiatric Association (DSM-5) provides an opportunity to examine the constructs underlying delirium as a clinical entity.Discussion: Altered consciousness has been regarded as a core feature of delirium; the fact that consciousness itself should be physiologically disrupted due to acute illness attests to its clinical urgency. DSM-5 now operationalises 'consciousness' as 'changes in attention'. It should be recognised that attention relates to content of consciousness, but arousal corresponds to level of consciousness. Reduced arousal is also associated with adverse outcomes. Attention and arousal are hierarchically related; level of arousal must be sufficient before attention can be reasonably tested.Summary: Our conceptualisation of delirium must extend beyond what can be assessed through cognitive testing (attention) and accept that altered arousal is fundamental. Understanding the DSM-5 criteria explicitly in this way offers the most inclusive and clinically safe interpretation.
KW - Arousal
KW - Attention
KW - Consciousness
KW - Delirium
KW - Diagnostic and Statistical Manual of Mental Disorders
UR - http://www.scopus.com/inward/record.url?scp=84908084293&partnerID=8YFLogxK
U2 - 10.1186/s12916-014-0141-2
DO - 10.1186/s12916-014-0141-2
M3 - Article
C2 - 25300023
AN - SCOPUS:84908084293
SN - 1741-7015
VL - 12
JO - BMC Medicine
JF - BMC Medicine
IS - 1
M1 - 141
ER -